Upadacitinib Found Effective in Achieving Remission in Crohn Disease, Including Biologic-Experienced Patients
In a real-world study of patients with Crohn disease, upadacitinib achieved 52.1% clinical remission at 12 weeks and 42.7% endoscopic remission at 6 months, with no new safety concerns reported.
Endemic Measles is a Clear and Present Danger, According to Stanford University Modeling Study
At current vaccination rates, measles could become endemic in the US again within 21 years; the threat extends to rubella, polio, and diphtheria, the study found.
Postpartum Hormonal Contraceptive Use Linked to Increased Risk of Depression
The increased risk of depression when oral contraceptives were started following childbirth was "instantaneous," researchers wrote, and was ~50% greater than nonuse.
Precision Obesity Medicine Breakthroughs To Lead DDW 2025 Presentations from Phenomix Sciences
Phenomix will showcase new data on prediction of adverse events to GLP-1 RA therapy, a new obesity sub-phenotype, and approaches to improve surgical outcomes.
Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
The Role for CGM in Glycemic Management Will Continue to Expand, Including in Prediabetes, Expert Says
CGM is now standard of care in T1D and evidence is solid for a role in insulin-treated T2D; Thomas Martens, MD, shares thoughts on CGM growth in the next 3-5 years.
New-Onset Type 2 Diabetes Tied to Higher Risk of Specific Obesity-Related Cancers
New data to be presented at ECO 2025 shows new-onset T2D is linked to increased risk of liver, pancreatic, and bowel cancers, but not endometrial or post-menopausal breast cancer.
How to Maximize CGM Data Presented in the Ambulatory Glucose Profile: Thomas Martens, MD, Illustrates
Martens, medical director of the International Diabetes Center (IDC) in Minneapolis, highlights an IDC resource that helps target problem areas in management of hyperglycemia.
Investigational Probiotic Drug Gains FDA Support for Phase 2 Obesity Trial
Northstrive Biosciences received positive FDA feedback for its IND application for EL-22, a probiotic-based treatment for obesity.
Smoking Rates Hit New Low, But Cervical Cancer Screening Still Lags: 2025 ACS Report
While smoking in the US continues to decline, the American Cancer Society reports mixed progress in major cancer risk factors, prevention, and screening.
Fentanyl Exposures in Children Up 10-Fold in 8 Years: Daily Dose
False Beliefs about MMR Vaccine, Measles Reach the Majority of US Adults: KFF Poll on Health Information & Trust
Misinformation about measles and the MMR vaccine has reached the majority of US adults and parents; most believe the vaccine is safe but many are still unconvinced.
Elderly Atopic Dermatitis Cases Up 85% in the US Since 1990, New Study Shows
New data also demonstrated mixed sex disparities in elderly atopic dermatitis prevalence.
GRAIL to Share Real-World Data from 100,000 Galleri Multi-Cancer Detection Tests at 2025 AACR Meeting
GRAIL announced plans to present new support for the Galleri test's ability to simultaneously screen for multiple cancers plus its accuracy for cancer signal of origin prediction.
Intermittent and Continuous Glucose Monitoring: Thomas Martens, MD, Details the Differences
Martens, Director of the International Diabetes Center, in Minneapolis, highlights the differences between the 2 methods and what the research has found on each.
Omnipod 5 Boosts Glycemic Control in MDI Users with T1D: Daily Dose
Suicide Prevention in Primary Care: A Family Physician on Screening, Risk, and Follow-Up
Suicide prevention falls squarely in the purview of primary care practitioners, says family physician Teresa Lovins, MD. She reviews an intervention with remarkable results.
Vaccination Attitudes in the US: Key Insights for Primary Care
A recent survey of US adults sheds light on public attitudes regarding RSV, influenza, COVID-19, MMR, and other key vaccines.
Early Menopause Was Associated with Increased Risk of Cognitive Decline, Depression within 2 Years
The findings suggest that women who experience early menopause (age <40 vs >50 years) may constitute a sex-specific high-risk group for cognitive decline.
One in Three Cases of Dementia May be Attributable to Hearing Loss: Population-Based Study
Interventions to protect or improve auditory health across the lifespan could be a cost-effective means of slowing the rapid rise of dementia in the US, authors wrote.